Evidence map›Paper›PMID 33088020›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2020

Recombinant GH treatment in a case of Costello syndrome with a 5-year follow-up.

Sirmen Kizilcan Cetin, Zeynep Siklar, Elif Ozsu, Zehra Aycan, Rukiye Uyanik, Meliha E Bilici, Aysegul Ceran, Merih Berberoglu

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sirmen Kizilcan CetinDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Zeynep SiklarDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Elif OzsuDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Zehra AycanDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Rukiye UyanikDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Meliha E BiliciDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Aysegul CeranDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Merih BerberogluDepartment of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey.
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Costello syndrome (CS) is a rare member of the group of neuro-cardio-facio-cutaneous diseases known as RASopathies. CS involves characteristic dysmorphic craniofacial features, cardiac defects, and increased cancer susceptibility, depending on the heterozygous activating germline mutations in

Indexed as

Costello syndromeGH deficiencyHRASmalignancy

Identifiers

PMID33088020
PMCPMC7534522
OpenAlexW3091060940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.